Haisco Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Haisco Pharmaceutical Group has a total shareholder equity of CN¥4.2B and total debt of CN¥2.1B, which brings its debt-to-equity ratio to 49.4%. Its total assets and total liabilities are CN¥6.9B and CN¥2.7B respectively. Haisco Pharmaceutical Group's EBIT is CN¥380.0M making its interest coverage ratio -3.5. It has cash and short-term investments of CN¥1.3B.
Key information
49.4%
Debt to equity ratio
CN¥2.07b
Debt
| Interest coverage ratio | -3.5x |
| Cash | CN¥1.29b |
| Equity | CN¥4.18b |
| Total liabilities | CN¥2.73b |
| Total assets | CN¥6.91b |
Recent financial health updates
Haisco Pharmaceutical Group (SZSE:002653) Has A Pretty Healthy Balance Sheet
Jul 04
These 4 Measures Indicate That Haisco Pharmaceutical Group (SZSE:002653) Is Using Debt Reasonably Well
Mar 19Recent updates
Is Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653) Trading At A 38% Discount?
Dec 19Haisco Pharmaceutical Group Co., Ltd.'s (SZSE:002653) Shares May Have Run Too Fast Too Soon
Nov 19Haisco Pharmaceutical Group's (SZSE:002653) Promising Earnings May Rest On Soft Foundations
Aug 22With Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653) It Looks Like You'll Get What You Pay For
Jul 25Haisco Pharmaceutical Group (SZSE:002653) Has A Pretty Healthy Balance Sheet
Jul 04Calculating The Fair Value Of Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653)
Jun 17These 4 Measures Indicate That Haisco Pharmaceutical Group (SZSE:002653) Is Using Debt Reasonably Well
Mar 19Risks To Shareholder Returns Are Elevated At These Prices For Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653)
Feb 27Financial Position Analysis
Short Term Liabilities: 002653's short term assets (CN¥2.9B) exceed its short term liabilities (CN¥1.4B).
Long Term Liabilities: 002653's short term assets (CN¥2.9B) exceed its long term liabilities (CN¥1.3B).
Debt to Equity History and Analysis
Debt Level: 002653's net debt to equity ratio (18.6%) is considered satisfactory.
Reducing Debt: 002653's debt to equity ratio has increased from 47.3% to 49.4% over the past 5 years.
Debt Coverage: 002653's debt is well covered by operating cash flow (24.8%).
Interest Coverage: 002653 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 08:37 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Haisco Pharmaceutical Group Co., Ltd. is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yue Gao | Changjiang Securities Co. LTD. |
| Shanshan Li | China Merchants Securities Co. Ltd. |
| Sophia Zhang | China Stock Investment Research Co. Ltd. (GZ500..com) |